| Menopause |
1 |
0.54 |
| Sexual Dysfunction in Female |
0 |
0.42 |
| Vaginal Discharge |
0 |
0.42 |
| Pain Management |
0 |
0.38 |
| Acute Pain |
0 |
0.28 |
| Sports Medicine |
0 |
0.28 |
| Human Papillomavirus |
0 |
0.27 |
| Incontinence |
0 |
0.25 |
| Skin and Soft Tissue Infection |
0 |
0.25 |
| Overuse Injury |
0 |
0.24 |
| Patient Safety |
0 |
0.22 |
| Tissue |
0 |
0.21 |
| Wound Management |
0 |
0.2 |
| Stress Incontinence |
0 |
0.18 |
| Lichen Sclerosus et Atrophicus |
0 |
0.17 |
| Aesthetic Medicine |
0 |
0.16 |
| Sexual Dysfunction |
0 |
0.15 |
| Urethra |
0 |
0.15 |
| Revenue and Practice Management |
0 |
0.14 |
| Vaginitis |
0 |
0.14 |
| Food and Drug Administration (FDA) |
0 |
0.13 |
| Dyspareunia |
0 |
0.1 |
| Pain |
0 |
0.1 |
| Platelet Count |
0 |
0.1 |
| Platelet-Derived Growth Factor |
0 |
0.09 |
| Postoperative Pain |
0 |
0.09 |
| Estrogen |
0 |
0.08 |
| Adverse Effects |
0 |
0.06 |
| Brachial |
0 |
0.06 |
| Epithelium |
0 |
0.06 |
| Sexual Health |
0 |
0.06 |
| Wound |
0 |
0.06 |
| Wound Healing |
0 |
0.06 |
| Complementary and Alternative Medicine |
0 |
0.05 |
| Cosmetic Dermatology |
0 |
0.05 |
| Genomic Medicine |
0 |
0.05 |
| Osteoarthritis |
0 |
0.05 |
| Urinary Tract Infection |
0 |
0.05 |
| Ablation |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Dorsum |
0 |
0.04 |
| Europe |
0 |
0.04 |
| Mesh |
0 |
0.04 |
| Muscle |
0 |
0.04 |
| Plasma |
0 |
0.04 |
| Quality of Life |
0 |
0.04 |
| Stress |
0 |
0.04 |
| Surgery |
0 |
0.04 |
| Vascular Endothelial Growth Factor |
0 |
0.04 |
| Topical Corticosteroid |
0 |
0.03 |
| Analgesia |
0 |
0.02 |
| Angiogenesis |
0 |
0.02 |
| Calcium |
0 |
0.02 |
| California |
0 |
0.02 |
| Corticosteroids |
0 |
0.02 |
| Cosmetics |
0 |
0.02 |
| Cytology |
0 |
0.02 |
| Edema |
0 |
0.02 |
| Fee for Service |
0 |
0.02 |
| Fibroblast Growth Factor |
0 |
0.02 |
| Genital Wart |
0 |
0.02 |
| Gland |
0 |
0.02 |
| Hormonal Therapy |
0 |
0.02 |
| Hospital |
0 |
0.02 |
| Hysterectomy |
0 |
0.02 |
| Insurance |
0 |
0.02 |
| Mobility |
0 |
0.02 |
| Ophthalmic |
0 |
0.02 |
| Palmar |
0 |
0.02 |
| Postoperative |
0 |
0.02 |
| Steroids |
0 |
0.02 |
| Tendonitis |
0 |
0.02 |
| Urinary Retention |
0 |
0.02 |